procarbazine has been researched along with Kidney Diseases in 3 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The expanding use of cytotoxic drugs in cancer therapy has resulted in a confusing and increasingly frequent array of severe renal complications." | 1.27 | Renal complications of cytotoxic therapy. ( Clarkson, AR; Healy, HG, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, H | 1 |
| Ogura, R | 1 |
| Tsukamoto, Y | 1 |
| Okada, M | 1 |
| Natsumeda, M | 1 |
| Isogawa, M | 1 |
| Yoshida, S | 1 |
| Fujii, Y | 1 |
| Healy, HG | 1 |
| Clarkson, AR | 1 |
| Price, P | 1 |
| Thompson, H | 1 |
| Bessell, EM | 1 |
| Bloom, HJ | 1 |
3 other studies available for procarbazine and Kidney Diseases
| Article | Year |
|---|---|
Advantages of dose-dense methotrexate protocol for primary central nervous system lymphoma: comparison of two different protocols at a single institution.
Topics: Academies and Institutes; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic C | 2013 |
Renal complications of cytotoxic therapy.
Topics: Animals; Antineoplastic Agents; Asparaginase; Cisplatin; Cyclophosphamide; Cytarabine; Dogs; Fluorou | 1983 |
Renal impairment following the combined use of high-dose methotrexate and procarbazine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Humans; | 1988 |